Howard Herman, MD
Otolaryngology · Stockbridge, GANPI 1053318774
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.3%), consulting fees and entertainment — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Spirair, Inc. at 43.5% of the total. Reporting peaked in 2024 at $3,415 and has fallen 73.5% since, to $905 in 2025. Among otolaryngology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $53.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spirair, Inc.$3K
- Stryker$1K
- Aerin Medical Inc.$586
- Regeneron Healthcare Solutions, Inc.$291
- Sanofi$222
- Optinose US, Inc.$217
- plus $1K from 16 others
Across 8 payments — averaging $39,761 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Olympus Winter & Ibe GmbH$318K
What the payments were for
- Consulting fees$2,50038%
- Food & beverage$3,86159%
- Entertainment$1452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spirair, Inc. | 3 | $2,827 |
| Stryker | 31 | $1,218 |
| Aerin Medical Inc. | 7 | $586 |
| Regeneron Healthcare Solutions, Inc. | 10 | $291 |
| Sanofi | 8 | $222 |
| Optinose US, Inc. | 11 | $217 |
| Inspire Medical Systems, Inc. | 5 | $207 |
| Intersect ENT, Inc. | 6 | $187 |
| GSK | 10 | $152 |
| Phathom Pharmaceuticals, Inc. | 3 | $92 |
| Kaleo, Inc. | 5 | $83 |
| Jazz Pharmaceuticals Inc. | 3 | $75 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
| Olympus America Inc. | 3 | $50 |
| Amgen(2 entities) | 3 | $48 |
| Merck | 3 | $43 |
| Alk-abello, Inc | 2 | $37 |
| Resmed Corp | 2 | $34 |
| Lilly USA, LLC | 1 | $27 |
| Novartis | 1 | $22 |
| Medtronic | 1 | $19 |
| Baudax Bio Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SeptAlign$5,654
- TURBALIGN$282
- VIVAER STYLUS$240
- RHINAER STYLUS$240
- XPRESS ENT DILATION SYSTEM$170
- AUDION ET DILATION SYSTEM$170
- FIAGON NAVIGATION UNIT$141
How this compares
$6,506 in reported general payments places this provider in the 90th percentile of 308 otolaryngology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 346 | $3,387 |
| Ipratropium Bromide | 106 | $2,927 |
| Omeprazole | 61 | $1,543 |
| Fluocinolone Acetonide Oil | 33 | $1,467 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 14 | $1,309 |
| Azelastine Hcl | 50 | $1,272 |
| Fluticasone Propionate | 44 | $586 |
| Mupirocin | 57 | $377 |
| Sucralfate | 12 | $340 |
| Pantoprazole Sodium | 21 | $266 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $204 |
| Clindamycin Hcl | 20 | $202 |
| Montelukast Sodium | 12 | $154 |
| Prednisone | 38 | $125 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 12 | $85 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Stockbridge
- Matthew KarenStockbridge$6K
- Dozier HoodFayetteville$347K
- Christopher MelroySavannah$298K
- Karen HoffmannAtlanta$223K
- Jose StolovitzkyAtlanta$81K
- Jonathan LindmanEvans$55K
- Gregory PostmaAugusta$37K
- Oswaldo HenriquezSmyrna$15K
- Donald BrowningLawrenceville$14K
- Robert GadlageDuluth$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.